Medicenna Therapeutics Corp.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-067/6/26 | New | $253,458 | $253,458 | Equity Only | 06b | SEC linkSEC |
| 2024-05-145/14/24 | New | $14,550,000 | $14,550,000 | Equity Only | 06b | SEC linkSEC |
| 2020-04-204/20/20 | Amended | $9,219,339 | $2,501,797 | Equity Only | 06b | SEC linkSEC |
| 2020-03-303/30/20 | New | $6,717,542 | $6,717,542 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Albert G. Beraldo | Director |
| Karen Dawes | Director |
| John Geltosky | Director |
| Angelos Georgakis | Director |
| David Hyman | Executive |
| Nageatte Ibrahim | Executive |
| Karim Lalji | Director |
| Fahar Merchant | Director, Executive |
| Rosemina Merchant | Executive |
| Chandra Panchal | Director |
| John Sampson | Director |
| Andrew Strong | Director |
| Richard Sutin | Director |
| Elizabeth Williams | Executive |
Industry: Biotechnology (See others in industry)
Address:
2 Bloor Street W Suite 903
Toronto, A6, M4W 3E2
Phone: 604-671-6673
Toronto, A6, M4W 3E2
Phone: 604-671-6673